Prostate Cancer: ASCO20 Virtual Scientific Program Highlights for the Advanced Practitioner
Morgane C. Diven, PharmD, BCOP
Phoenix VA Health Care System
J Adv Pract Oncol 2020;11(6):562-568 |
© 2020 Harborside™
Morgane C. Diven, PharmD, BCOP, of Phoenix VA Health Care System, breaks down abstract summaries published in The ASCO Post on a novel target, imaging agent, and androgen-deprivation therapy for prostate cancer, along with their implications for advanced practitioners.
For access to the full length article, please sign in